These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10993129)

  • 1. Non-compliance with pharmacotherapy of depression is associated with a sensation seeking personality.
    Ekselius L; Bengtsson F; von Knorring L
    Int Clin Psychopharmacol; 2000 Sep; 15(5):273-8. PubMed ID: 10993129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personality disorder comorbidity with major depression and response to treatment with sertraline or citalopram.
    Ekselius L; von Knorring L
    Int Clin Psychopharmacol; 1998 Sep; 13(5):205-11. PubMed ID: 9817625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in personality traits during treatment with sertraline or citalopram.
    Ekselius L; Von Knorring L
    Br J Psychiatry; 1999 May; 174():444-8. PubMed ID: 10616614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic appraisal of citalopram in the management of single-episode depression.
    Sclar DA; Skaer TL; Robison LM; Galin RS
    J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):47S-54S. PubMed ID: 10507508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitioners.
    Akerblad AC; Bengtsson F; Ekselius L; von Knorring L
    Int Clin Psychopharmacol; 2003 Nov; 18(6):347-54. PubMed ID: 14571155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
    Behnke K; Søgaard J; Martin S; Bäuml J; Ravindran AV; Agren H; Vester-Blokland ED
    J Clin Psychopharmacol; 2003 Aug; 23(4):358-64. PubMed ID: 12920411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reboxetine plus citalopram for refractory depression not responding to venlafaxine: possible mechanisms.
    Dursun SM; Devarajan S
    Psychopharmacology (Berl); 2001 Feb; 153(4):497-8. PubMed ID: 11243498
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of intravenous citalopram compared with oral citalopram for severe depression. Safety and efficacy data from a double-blind, double-dummy trial.
    Guelfi JD; Strub N; Loft H
    J Affect Disord; 2000 Jun; 58(3):201-9. PubMed ID: 10802128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of an acute antidepressant response to fluoxetine and sertraline.
    Flament MF; Lane RM; Zhu R; Ying Z
    Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life measurement in antidepressant trials. Is there an added value?
    De Fruyt J; Demyttenaere K
    Psychother Psychosom; 2009; 78(4):212-9. PubMed ID: 19401621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).
    Wade AG; Schlaepfer TE; Andersen HF; Kilts CD
    J Psychiatr Res; 2009 Feb; 43(5):568-75. PubMed ID: 18954875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression.
    Lépine JP; Goger J; Blashko C; Probst C; Moles MF; Kosolowski J; Scharfetter B; Lane RM
    Int Clin Psychopharmacol; 2000 Sep; 15(5):263-71. PubMed ID: 10993128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
    Ferguson JM; Shrivastava RK; Stahl SM; Hartford JT; Borian F; Ieni J; McQuade RD; Jody D
    J Clin Psychiatry; 2001 Jan; 62(1):24-9. PubMed ID: 11235924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo.
    Kocsis JH; Schatzberg A; Rush AJ; Klein DN; Howland R; Gniwesch L; Davis SM; Harrison W
    Arch Gen Psychiatry; 2002 Aug; 59(8):723-8. PubMed ID: 12150648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influences of the Big Five personality traits on the treatment response and longitudinal course of depression in patients with acute coronary syndrome: A randomised controlled trial.
    Kim SY; Stewart R; Bae KY; Kim SW; Shin IS; Hong YJ; Ahn Y; Jeong MH; Yoon JS; Kim JM
    J Affect Disord; 2016 Oct; 203():38-45. PubMed ID: 27280961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Older community residents with depression: long-term treatment with sertraline. Randomised, double-blind, placebo-controlled study.
    Wilson KC; Mottram PG; Ashworth L; Abou-Saleh MT
    Br J Psychiatry; 2003 Jun; 182():492-7. PubMed ID: 12777339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Citalopram and desmethylcitalopram for psychiatric patients].
    Linnet K; Olesen OV
    Ugeskr Laeger; 1996 Aug; 158(35):4920-3. PubMed ID: 8801700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
    Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ;
    Lancet Oncol; 2007 Jul; 8(7):603-12. PubMed ID: 17548243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.